Evidence map›Paper›PMID 42832566›Full record

ArticlePLoS neglected tropical diseases2026

Virological and epidemiological investigations of a severe hand foot and mouth disease outbreak, Vietnam, 2023.

Lam Anh Nguyet, Nguyen To Anh, Du Tuan Quy, Nguyen Thi Thu Hong, Ngo Ngoc Quang Minh, Phung Nguyen The Nguyen, Pham Van Quang, Do Duong Kim Han, Nguyen Thi Han Ny, Le Nguyen Truc Nhu and 17 more

Abstract read
PubMed Publisher
In one paragraph

Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Lam Anh NguyetOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Nguyen To AnhOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Du Tuan QuyChildren's Hospital 1, Ho Chi Minh City, Vietnam.
Nguyen Thi Thu HongOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.ORCID https://orcid.org/0009-0004-4993-6616
Ngo Ngoc Quang MinhChildren's Hospital 1, Ho Chi Minh City, Vietnam.
Phung Nguyen The NguyenUniversity of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
Pham Van QuangChildren's Hospital 1, Ho Chi Minh City, Vietnam.
Do Duong Kim HanOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Nguyen Thi Han NyOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Le Nguyen Truc NhuOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Truong Hoang Chau TrucOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Cao Thu ThuyOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Nhung Ngoc HoangOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.ORCID https://orcid.org/0000-0003-4670-9317
Tran Ba ThienOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.ORCID https://orcid.org/0009-0007-2964-7747
Le Kim ThanhOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Nguyen Thanh HungChildren's Hospital 1, Ho Chi Minh City, Vietnam.
Truong Huu KhanhChildren's Hospital 1, Ho Chi Minh City, Vietnam.
Cao Minh HiepChildren's Hospital 1, Ho Chi Minh City, Vietnam.
Nghiem My NgocHospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Nguyen Thanh DungHospital for Tropical Diseases, Ho Chi Minh City, Vietnam.
Le Nguyen Thanh NhanChildren's Hospital 1, Ho Chi Minh City, Vietnam.
Nguyen Van Vinh ChauDepartment of Health, Ho Chi Minh City, Vietnam.
Ha Manh TuanUniversity of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
H Rogier van DoornOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Marc ChoisyOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Tran Tan ThanhOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Le Van TanOxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.ORCID https://orcid.org/0000-0002-1791-3901

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report on the virological and epidemiological features of a severe hand foot and mouth disease outbreak in Vietnam in 2023. Enterovirus A71 (EV-A71) subgenogroup B5, first emerging around November 2022, and imported into Vietnam through a single introduction, was the primary cause. Convalescent plasma collected from patients infected with subgenogroups B5 in 2014 and 2023 could neutralize both contemporary viruses with comparable titers, suggesting no evidence of immune evasion. However, at one and six months before the start of the outbreak, only 6.7% of 0- < 3 year-old children in Ho Chi Minh City, an epicenter of the outbreak, had neutralizing antibodies against EV-A71. Seroprevalence increased as the outbreak progressed, coinciding with a drop in EV-A71 infected patients residing in Ho Chi Minh City, suggesting that serosurveillance could be a useful tool to assess the risk of pathogen emergence. Our collective findings have provided novel insights into the epidemiological factors driving EV-A71 emergence, and therefore would inform outbreak preparedness and response, and in particular the development of serosurveillance-based approach to assess the risk of pathogen emergence. EV-A71 infection represents an ongoing public health threat, currently affecting countries in the Asia-Pacific region, but with a high potential to become a global problem, and therefore should be closely monitored.

Indexed as

Disease OutbreaksEnterovirus A, HumanHand, Foot and Mouth DiseaseAntibodies, NeutralizingAntibodies, ViralChild, PreschoolFemaleHumansInfantMaleSeroepidemiologic StudiesVietnamAntibodies, NeutralizingAntibodies, Viral

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.